Document is current

Article History

Received: 31 January 2020

Accepted: 24 April 2020

First Online: 29 May 2020

Compliance with ethical standards

:

: Cook Medical, Bloomington, IN, USA; Boston Scientific, Marlborough, MA, USA; Prytime Medical Devices, Boerne, TX, USA; Edwards Lifesciences, Irvine, CA, USA; LeMaitre Vascular, Burlington, MA, USA; Merit Medical, South Jordan, UT, USA; REBOA Medical AS, Norway; Medtronic, Minneapolis, MN, USA; Tokai Medical Products, Aichi, Japan; Minimally Invasive Technologies, Moscow, Russia, provided the catheters used for this study. No other support was provided. S.M. Vrancken, B.L.S. Borger van der Burg, P.J.E.M. Vrancken, G.A. Kock and R. Hoencamp report no proprietary or commercial interest in any product mentioned or concept discussed in this article. Dr. Rasmussen is an inventor of REBOA and REBOA-like technology and is part of patents that have been declared and approved in several countries in this topic area. He has no relevant financial relationships to medical device industry in this topic area to disclose. The authors declare that there are no conflicts of interest that could inappropriately influence (bias) their work. We confirm that this submission has not been published elsewhere.